Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to collect information on how NovoPen® 6 works with Tresiba® & Fiasp® for treatment of people with type 1 diabetes and see if the use of NovoPen® 6 can help participants achieve better blood sugar levels. Participants will use Tresiba® & Fiasp® in NovoPen® 6 as prescribed to participants by the study doctor. NovoPen® 6 is a smart pen, which collects and stores the date and time of injections and number of units of insulin participants have taken. NovoPen® 6 can transfer participants insulin dosing information to the mobile application, which participants use to see their continuous blood sugar level. This will allow participants to see their insulin doses along with continuous blood sugar level in the mobile application. Participants will keep using their own continuous blood sugar monitoring device and the mobile application to see these data during the study. The study will last for about 9-11 months. Participants will be asked to complete 2 questionnaires in this study. One questionnaire is about overall satisfaction of using a digital health solution and other is about quality of life. Participants will complete these questionnaires during their normally scheduled visit with the study doctor, on 2 separate occasions

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05069545
Study type Observational
Source Novo Nordisk A/S
Contact Novo Nordisk
Phone (+1) 866-867-7178
Email [email protected]
Status Not yet recruiting
Start date September 25, 2021
Completion date March 6, 2023

See also
  Status Clinical Trial Phase
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT03605329 - Evaluation of the Severity of Cardiovascular Autonomic Neuropathy in Type 1 Diabetic Patients With OSAS N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Recruiting NCT04443153 - Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes N/A
Recruiting NCT04521634 - Glycaemic Variability in Acute Stroke
Completed NCT04569994 - A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes Phase 1
Completed NCT04089462 - Effects of Frequency and Duration of Exercise in People With Type 1 Diabetes A Randomized Crossover Study N/A
Active, not recruiting NCT03143816 - Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study—STAT Study Phase 4
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A
Completed NCT04042207 - Diabeloop for Highly Unstable Type 1 Diabetes N/A
Recruiting NCT04974528 - Afrezza® INHALE-1 Study in Pediatrics Phase 3
Recruiting NCT03988764 - Monogenic Diabetes Misdiagnosed as Type 1
Not yet recruiting NCT04869761 - Stem Cell Therapy for Chronic Kidney Disease Phase 1
Not yet recruiting NCT04304963 - Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS
Recruiting NCT03682640 - Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes Phase 2
Withdrawn NCT03242005 - The PSIQS Study - User Experience With Pro-Set N/A
Recruiting NCT02953249 - Wound Healing After Tooth Extraction in Individuals With Type 1 Diabetes Mellitus N/A
Completed NCT02839174 - Type One Diabetes and Low Carb Study N/A
Completed NCT02629263 - The Effect of Viscous Fiber on Glycemic Control in Individuals With Diabetes